Skip to main content

Peer Review reports

From: A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties

Original Submission
1 Jun 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
27 Oct 2015 Editorially accepted
4 Nov 2015 Article published 10.1186/s12885-015-1868-7

You can find further information about peer review here.

Back to article page